Clinical Trial Update: AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial of AKITA Inhaled Steroid Suspension for Inhalation (AICS) in asthma has completed, according to a clinical trials update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AKITA Inhaled Steroid Suspension for Inhalation (AICS)

Snippet

Sponsor: Activaero GmbH | Conditions: Asthma | Phase 2 | Status: COMPLETED